Get started
Genscript Biotech CorpGenscript Biotech CorpGenscript Biotech Corp

Genscript Biotech Corp

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

GNNSF chart

Upcoming earnings

Next report date
Report period
H1 2024
EPS estimate
0.03USD
Revenue estimate
‪645.40 M‬USD

Key stats

Market capitalization
‪2.90 B‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.05USD
Net income (FY)
‪−95.70 M‬USD
Revenue (FY)
‪841.49 M‬USD
Shares float
‪1.07 B‬
Beta (1Y)
1.48

About Genscript Biotech Corp

Sector
Health Technology
Industry
Biotechnology
CEO
Weihui Shao
Website
genscript.com
Headquarters
Nanjing
Employees (FY)
‪6.94 K‬
Founded
2002
ISIN
KYG3825B1059
FIGI
BBG00H8V6R36
Genscript Biotech Corp. is a holding company, which engages in the manufacture and sale of life sciences research products and services. It operates through the following segments: Bio-science Services and Products; Precision Immune-cell Therapy; and Industrial Synthetic Biology Products. The Bio-science Services and Products segment includes life sciences research services, life sciences research catalogue products, and preclinical drug development services. The Precision Immune-cell Therapy segment discovers and develops therapies for the treatment of liquid tumour through optimised CAR structures and the development of bispecific CAR-T therapies. The Industrial Synthetic Biology Products segment comprises of the construction of non-pathogenic microbial strains and industrial enzyme development and production. The company was founded by Fang Liang Zhang, Lu Quan Wang, and Ye Wang in 2002 and is headquartered in Nanjing, China.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of GNNSF is 1.50 USD — it has decreased by 1.96% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Genscript Biotech Corp stocks are traded under the ticker GNNSF.
Genscript Biotech Corp is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
GNNSF stock is 2.00% volatile and has beta coefficient of 1.48. Check out the list of the most volatile stocks — is Genscript Biotech Corp there?
Yes, you can track Genscript Biotech Corp financials in yearly and quarterly reports right on TradingView.
GNNSF stock has fallen by 25.00% compared to the previous week, the month change is a 25.00% fall, over the last year Genscript Biotech Corp has showed a 41.41% decrease.
GNNSF net income for the last quarter is ‪−1.90 M‬ USD, while the quarter before that showed ‪−93.58 M‬ USD of net income which accounts for 97.97% change. Track more Genscript Biotech Corp financial stats to get the full picture.
Today Genscript Biotech Corp has the market capitalization of ‪2.89 B‬, it has decreased by 9.36% over the last week.
Like other stocks, GNNSF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Genscript Biotech Corp stock right from TradingView charts — choose your broker and connect to your account.
GNNSF reached its all-time high on Jul 19, 2021 with the price of 5.30 USD, and its all-time low was 0.89 USD and was reached on Sep 28, 2017.
See other stocks reaching their highest and lowest prices.
As of Apr 26, 2024, the company has ‪6.94 K‬ employees. See our rating of the largest employees — is Genscript Biotech Corp on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Genscript Biotech Corp technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Genscript Biotech Corp stock shows the strong sell signal. See more of Genscript Biotech Corp technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Genscript Biotech Corp future price: according to them, GNNSF price has a max estimate of 3.96 USD and a min estimate of 2.94 USD. Read a more detailed Genscript Biotech Corp forecast: see what analysts think of Genscript Biotech Corp and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Genscript Biotech Corp EBITDA is ‪−316.90 M‬ USD, and current EBITDA margin is −37.66%. See more stats in Genscript Biotech Corp financial statements.